News
However, yesterday GSK announced that the FDA has extended the review period for Blenrep to give the agency time to review ...
GSK’s blood cancer drug Blenrep has been reapproved by the EU medicines regulator after it was removed from sale in 2023 because a trial failed to show it was superior to other treatments.
Parents of children with severe peanut allergies are calling on the HSE to make a breakthrough treatment available in Ireland ...
Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on ...
ImCheck Therapeutics receives EMA Orphan Drug Designation for ICT01 for treatment for acute myeloid leukemia: Marseille, France Thursday, July 24, 2025, 15:00 Hrs [IST] ImCheck Th ...
THE EUROPEAN Hematology Association-European Medicines Agency (EHA2025-EMA) Joint Symposium on minimal residual disease ...
Novo Nordisk A/S (NYSE:NVO) is one of the 10 Best Growth Stocks to Buy With Huge Upside Potential. On June 23, Novo Nordisk A/S (NYSE:NVO) announced that the European Medicines Agency’s Committee for ...
The European Union’s health regulator has lifted the temporary restriction on the use of French drugmaker Valneva’s ...
The European Medicines Agency also said that extra doses of the Moderna and Pfizer-BioNTech vaccines could be given to people with underlying health conditions as early as 28 days after a second dose.
European Medicines Agency Warns of Diabetics’ Risk Amid Ozempic Shortage Some doctors have been prescribing Ozempic for weight loss Use as slimming treatment may endanger diabetics, EMA says ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results